|Bid||4.0900 x 1300|
|Ask||4.1100 x 1200|
|Day's Range||3.8400 - 4.2000|
|52 Week Range||3.5700 - 19.8400|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Reata (RETA) reports a narrower-than-expected loss for the first quarter of 2022 while revenues miss estimates.
A look at the shareholders of Lyell Immunopharma, Inc. ( NASDAQ:LYEL ) can tell us which group is most powerful. Large...
Strong demand for Sarepta's (SRPT) DMD drugs boosts its top line in the first quarter. Stock up in after-market trading.